longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Volitionrx

VNRX

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.07, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 20/45, the industry Median -0.28.

-0.0713xP/E
$0.23Stock price
$-3.29Earnings per share
-0.0713xP/E
Stock price$0.23Earnings per share$-3.29

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.10x
Typical range
-1.60x–-0.35x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.38x94.03%$6.05B
MMEDUSMiniMed
-17.56x146.72%$5.51B
NEOGUSNeogen
-337.85x316.68%$2.67B
ESTAUSEstablishment Labs
-48.31x30.16%$1.88B
XRAYUSDentsply Sirona
-3.19x113.34%$1.74B
KIDSUSOrthopediatrics
-14.26x27.74%$566.32M
CERSUSCerus
-68.93x56.25%$467.54M
SMTIUSSanara Medtech
-10.01x104.59%$320.48M
OSURUSOraSure Tech
-5.45x29.79%$267.60M
RXSTUSRxSight
-4.21x0.58%$197.57M
SKYAUSSkyAI
-0.21x--$83.90M
TELAUSTela Bio
-1.36x17.47%$56.12M
ZTEKFUSZENTEK LTD
-7.15x--$53.65M
XTNTUSXtant Med
-4.46x477.77%$49.69M
RMTIUSRockwell Medical
-6.59x32.67%$34.54M
NSPRUSInspireMD
-0.55x--$28.80M
RVPUSRetractable Tech
-5.73x--$20.66M
CUPRUSCuprina
-4.95x--$17.86M
LUCYUSInnovative Eyewear
-1.03x--$7.93M
AIDXUS20/20 Biolabs
-0.73x44.74%$5.22M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.